Inventor · Mountain View, CA, US

Bing Zheng

24Patents
8h-index
17Co-inventors
68Inventor score

Filing activity: Jul 15, 2008 → Apr 19, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8545850B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 37 Active
US8088378B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 29 Active
US9845355B2 Humanized anti-CD79b antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 19 Active
US8691531B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 18 Active
US9896506B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 18 Active
US8362213B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Chemistry; Metallurgy 17 Active
US8466260B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 15 Active
US8617559B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Chemistry; Metallurgy 14 Active
US9360484B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 6 Active
US9017951B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Chemistry; Metallurgy 6 Active
US10501545B2 Anti-CLL-1 antibodies and methods of use Chemistry; Metallurgy 4 Active
US10494432B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 3 Active
US10544218B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 3 Active
US10981987B2 Humanized anti-CD79b antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 3 Active
USRE48558E1 Anti-CD79B antibodies and immunoconjugates and methods of use General 2 Active
US10239947B2 Anti-CLL-1 antibodies and immunoconjugates Physics 1 Active
US10227412B2 Anti-CLL-1 antibodies and immunoconjugates Physics 1 Active
US10266597B2 Anti-CLL-1 antibodies and immunoconjugates Physics 1 Active
US9751946B2 Anti-CLL-1 antibodies and immunoconjugates Physics 1 Active
US10639378B2 Silvestrol antibody-drug conjugates and methods of use Human Necessities 1 Active
US11466087B2 Anti-CLL-1 antibodies and methods of use Chemistry; Metallurgy 0 Active
US11866496B2 Humanized anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 0 Active
US11648315B2 Silvestrol antibody-drug conjugates and methods of use Human Necessities 0 Active
US11084877B2 Anti-CLL-1 antibodies and immunoconjugates Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.